Inhibitory effects of anti-rheumatic drugs on vascular endothelial growth factor in cultured rheumatoid synovial cells (Q77774914)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10337031%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Inhibitory effects of anti-rheumatic drugs on vascular endothelial growth factor in cultured rheumatoid synovial cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10337031%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

M Nagashima

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10337031%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

S Yoshino

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10337031%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

H Aono

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10337031%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

M Takai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10337031%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

M Sasano

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10337031%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 May 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10337031%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10337031%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10337031%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10337031%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

360-365

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10337031%20AND%20SRC:MED&resulttype=core&format=json

Differences in the effects of the antirheumatic drugs, bucillamine and D-penicillamine, on mitogen-induced proliferation of mouse spleen cells

8 December 2019

cites work

1 reference

12 December 2020

Spontaneous production of an interleukin 1-like factor by cloned rheumatoid synovial cells in long-term culture

1 reference

12 December 2020

The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis

1 reference

12 December 2020

Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo.

1 reference

12 December 2020

Interleukin-8 in inflammatory rheumatic diseases: synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate

1 reference

12 December 2020

Sulphasalazine inhibition of human granulocyte activation by inhibition of second messenger compounds

1 reference

12 December 2020

Vascular permeability factor mRNA and protein expression in human kidney

1 reference

12 December 2020

Regulation of B cell function by bucillamine, a novel disease-modifying antirheumatic drug

1 reference

12 December 2020

Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis

1 reference

12 December 2020

Expression of Vascular Endothelial Growth Factor in Capillary Hemangioblastoma

1 reference

12 December 2020

Immunosuppression by the disease modifying antirheumatic drug bucillamine: inhibition of human T lymphocyte function by bucillamine and its metabolites

1 reference

12 December 2020

Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract

1 reference

12 December 2020

Vascular permeability factor gene expression in normal and neoplastic human ovaries

1 reference

12 December 2020

Mechanism of action of methotrexate: experimental evidence that methotrexate blocks the binding of interleukin 1 beta to the interleukin 1 receptor on target cells.

1 reference

12 December 2020

Expression of mRNA for vascular endothelial growth factor in human placenta

1 reference

12 December 2020

Leukotrien B4-induced interleukin-1 beta in synovial cells from patients with rheumatoid arthritis

1 reference

12 December 2020

Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome

1 reference

12 December 2020

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

1 reference

12 December 2020

Effects of gold sodium thiomalate on interferon stimulation of C2 synthesis and HLA-DR expression by human monocytes

1 reference

12 December 2020

Dexamethasone inhibition of interleukin 1 beta production by human monocytes. Posttranscriptional mechanisms

1 reference

12 December 2020

Inhibition of production of macrophage-derived angiogenic activity by the anti-rheumatic agents gold sodium thiomalate and auranofin

1 reference

12 December 2020

Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine

1 reference

12 December 2020

Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells

1 reference

12 December 2020

Inhibition of in vitro vascular endothelial cell proliferation and in vivo neovascularization by low-dose methotrexate

1 reference

12 December 2020

Inhibitory effects of sulfasalazine and related compounds on superoxide production by human polymorphonuclear leukocytes

1 reference

12 December 2020

Vascular endothelial growth factor is a secreted angiogenic mitogen

1 reference

12 December 2020

Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1beta

1 reference

12 December 2020

Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis

1 reference

12 December 2020

Methotrexate action in rheumatoid arthritis: stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells

1 reference

12 December 2020

Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis

1 reference

12 December 2020

Mechanism of dexamethasone suppression of brain tumor-associated vascular permeability in rats. Involvement of the glucocorticoid receptor and vascular permeability factor

1 reference

12 December 2020

Direct suppression of human synovial cell proliferation in vitro by salazosulfapyridine and bucillamine

1 reference

12 December 2020

[Effects of disease modifying antirheumatic drugs (DMARDs) and DEX on IL-1 beta and IL-6 production by IL-1 beta stimulated synovial culture cells]

1 reference

12 December 2020

Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids

1 reference

12 December 2020

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

1 reference

12 December 2020

The pharmacokinetics of intramuscular gold sodium thiomalate in normal volunteers

1 reference

12 December 2020

Clinical pharmacology of very low dose methotrexate for use in rheumatoid arthritis

1 reference

12 December 2020

Inhibition of human endothelial cell proliferation by gold compounds

1 reference

12 December 2020

Dexamethasone inhibits feedback regulation of the mitogenic activity of tumor necrosis factor, interleukin-1, and epidermal growth factor in human fibroblasts

1 reference

12 December 2020

Control of oxidative damage in rheumatoid arthritis by gold(I)-thiolate drugs.

1 reference

12 December 2020